CD34 and amyotrophic lateral sclerosis: We have recently shown that unmodified human bone marrow CD34+ (hBM34+) stem cells intravenously transplanted into symptomatic ALS mice dose-dependently differentiate into endothelial cells and engraft into the capillary walls in the cervical and lumbar spinal cords at 4 weeks post-transplantation [38].